Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Cholecalciferol + risedronate sodium by Dongkook Pharmaceutical for Osteoporosis: Likelihood of Approval
Cholecalciferol + risedronate sodium is under clinical development by Dongkook Pharmaceutical and currently in Phase I for Osteoporosis. According to...
Cholecalciferol + risedronate sodium by Dongkook Pharmaceutical for Post Menopausal Osteoporosis: Likelihood of Approval
Cholecalciferol + risedronate sodium is under clinical development by Dongkook Pharmaceutical and currently in Phase I for Post Menopausal Osteoporosis....
DKFMA-102 by Dongkook Pharmaceutical for Prostate Cancer: Likelihood of Approval
DKFMA-102 is under clinical development by Dongkook Pharmaceutical and currently in Phase III for Prostate Cancer. According to GlobalData, Phase...
DKF-340 by Dongkook Pharmaceutical for Inflammation: Likelihood of Approval
DKF-340 is under clinical development by Dongkook Pharmaceutical and currently in Phase I for Inflammation. According to GlobalData, Phase I...